Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk
AbstractBeginning in the late 1990s, a movement began within the pain management field focused upon the underutilization of opioids, thought to be a potentially safe and effective class of pain medication. Concern for addiction and misuse were present at the start of this shift within pain medicine, and an emphasis was placed on developing reliable and valid methods and measures of identifying those at risk for opioid misuse. Since that time, the evidence for the safety and effectiveness of chronic opioid therapy (COT) has not been established. Rather, the harmful, dose-dependent deleterious effects have become clearer, including addiction, increased risk of injuries, respiratory depression, opioid induced hyperalgesia, and death. Still, many individuals on low doses of opioids for long periods of time appear to have good pain control and retain social and occupational functioning. Therefore, we propose that the question, “Who is at risk of opioid misuse?” should evolve to, “Who may benefit from COT?” in light of the current evidence. View Full-Text
Share & Cite This Article
Huber, E.; Robinson, R.C.; Noe, C.E.; Van Ness, O. Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk. Healthcare 2016, 4, 29.
Huber E, Robinson RC, Noe CE, Van Ness O. Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk. Healthcare. 2016; 4(2):29.Chicago/Turabian Style
Huber, Elizabeth; Robinson, Richard C.; Noe, Carl E.; Van Ness, Olivia. 2016. "Who Benefits from Chronic Opioid Therapy? Rethinking the Question of Opioid Misuse Risk." Healthcare 4, no. 2: 29.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.